An experimental Alzheimer’s drug has received unanimous approval from a Food and Drug Administration advisory panel. The drug, called donanemab, is made by Eli Lilly…
Posts published in “FDA”
Primary care provider engagement could be key in increasing the pace and scope of treatment of early-stage Alzheimer’s disease, according to a new report. By…
Companies in the senior housing space are gearing up to give residents a second Covid-19 vaccine booster following new approvals from the FDA and CDC…